Transfer RNAs Have a Surprising Role in Breast Cancer Growth

A particular leucine-ferrying tRNA is more abundant in cancerous cells than healthy ones, and lowering its levels inhibits cancer growth, a study finds.

Written byNatalia Mesa, PhD
| 4 min read
A colored microscopy image of a dividing breast cancer cell
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

For many years, scientists believed that transfer RNAs are simple shuttles that bring amino acids to ribosomes. But a growing number of studies find that they can alter important cellular processes by influencing gene expression, including helping cancers grow. Now, researchers have found that tRNAs can speed up or slow breast cancer metastasis by accelerating the translation of growth genes.

In a study published in Nature Cancer on December 12, a team from the Rockefeller University and the University of California, San Francisco reports that tumor cells exhibit elevated levels of tRNAs that are required to assemble growth-promoting proteins. And in a twist, slightly different tRNAs that carry the same amino acid can have opposing effects on metastasis.

“It’s truly fascinating how cancer cells can manipulate the genetic code to their own advantage,” says Hannah Benisty, a cancer biologist at the Centre for Genomic Research in Spain who was not ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies